A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2006
10/26/2006	CA2574603A1 Oligonucleotides comprising a ligand tethered to a modified or non-natural nucleobase
10/25/2006	EP1715043A2 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
10/25/2006	EP1715042A1 EPITOPE/PEPTIDE RECOGNIZED BY HLA-A2402-RESTRCITED Ep-CAM-SPECIFIC CTL AND USE OF THE SAME
10/25/2006	EP1714969A2 Immunostimulatory nucleic acid molecules
10/25/2006	EP1714967A1 Antiparasitic artemisinin derivatives
10/25/2006	EP1714966A1 Naphthylidine derivative having hiv integrase inhibitory activity
10/25/2006	EP1714965A1 Composition containing solifenacin succinate
10/25/2006	EP1714963A1 Process for the Preparation of Valsartan and its Intermediates
10/25/2006	EP1714961A1 Indazole compound and pharmaceutical use thereof
10/25/2006	EP1714960A1 Novel therapeutic agent for amyotrophic lateral sclerosis (als) or disease attributable to als
10/25/2006	EP1714676A2 Use of N-substituted-1,5-dideoxy-1,5-imino-D-glucitol compounds for treating hepatitis virus infections
10/25/2006	EP1714660A1 Uronic acid and probiotics
10/25/2006	EP1714658A1 Dietary supplement comprising antioxidant agents and carnitine or a precursor thereof, to be used as an aid to fertility in men and women
10/25/2006	EP1714657A1 Solid formulation for dialysis and process for producing the same
10/25/2006	EP1714656A1 Ed-71 preparation
10/25/2006	EP1714655A1 Use of sodium channel blockers and their analogues for the treatment of nicotine dependency
10/25/2006	EP1714654A1 Drug for inhibiting vascular intimal hyperplasia
10/25/2006	EP1714653A1 Aqueous solution preparation containing camptothecins
10/25/2006	EP1714652A2 Use of thiazolidinediones to prevent or delay onset of niddm
10/25/2006	EP1714651A1 Use of angiotensin II receptor antagonists for treating acute myocardial infarction
10/25/2006	EP1714650A1 Arginine-containing compositions for increasing blood flow
10/25/2006	EP1714649A2 L-Valine for hepatic diseases
10/25/2006	EP1714648A1 Combination drug
10/25/2006	EP1714647A1 Use of agomelatin in the manufacture of a medicament for the treatment of bipolar disorders
10/25/2006	EP1714646A1 Pharmaceutical composition containing bakuchiol for treating osteoporosis in women
10/25/2006	EP1714645A1 Pharmaceutical composition containing bakuchiol for treating breast cancer in women
10/25/2006	EP1714644A1 Pharmaceutical compositions for the treatment of ulcerations
10/25/2006	EP1714641A2 Osmotic device containing a venlafaxine salt and a salt having a common ion
10/25/2006	EP1714640A1 Stabilised external skin treatment composition comprising retinol.
10/25/2006	EP1714564A1 Method for treatment and prevention of respiratory insufficiency
10/25/2006	EP1714561A2 Process for the heterotrophic production of microbial products with high concentration of omega-3 highly unsaturated fatty acids
10/25/2006	EP1713915A2 RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING MULTIFUNCTIONAL SHORT INTERFERING NUCLEIC ACID (MULTIFUNCTIONAL siNA)
10/25/2006	EP1713823A2 Hcv ns-3 serine protease inhibitors
10/25/2006	EP1713822A2 Hcv ns-3 serine protease inhibitors
10/25/2006	EP1713820A1 Selective estrogen receptor modulators
10/25/2006	EP1713818A1 Macrolides with antiinflammatory activity
10/25/2006	EP1713815A1 Pth agonists
10/25/2006	EP1713814A1 Bicyclic pyrazolo-fused compounds as protein kinase modulators
10/25/2006	EP1713813A2 POLYMORPHIC FORMS OF A GABA sb A /sb AGONIST
10/25/2006	EP1713810A1 Diazabicyclic aryl derivatives as nicotinic acetylcholine receptor ligands
10/25/2006	EP1713809A1 Dimeric azacyclic compounds and their use
10/25/2006	EP1713807A1 Vanilloid receptor ligands and their use in treatments
10/25/2006	EP1713806A1 Compounds and compositions as protein kinase inhibitors
10/25/2006	EP1713805A1 Kinase inhibitors
10/25/2006	EP1713804A1 Cycloalkyl substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, method for the production thereof and their use as medicaments
10/25/2006	EP1713803A1 7-phenylamino-4-quinolone-3-carboxylic acid derivatives, methods for production and use thereof as medicaments
10/25/2006	EP1713798A2 C10 cyclopentyl ester substituted taxanes
10/25/2006	EP1713797A1 1-ISOPROPYL-2-OXO-1,2-DIHYDROPYRIDINE-3-CARBOXAMIDE DERIVATIVES HAVING 5-HT sb 4 /sb RECEPTOR AGONISTIC ACTIVITY
10/25/2006	EP1713795A2 Candesartan cilexetil polymorphs
10/25/2006	EP1713793A2 Pyrimidinone compounds useful as kinase inhibitors
10/25/2006	EP1713792A2 SALT FORMS OF 4-(4-METHYLPIPERAZIN-1-YLMETHYL)-n- 4-METHYL-3 -(4-PYRIDIN-3-YL)PYRIMIDIN-2-YLAMINO)PHENYL -BENZAMIDE
10/25/2006	EP1713791A1 5-fluoro-, chloro- and cyano-pyridin-2-yl-tetrazoles as ligands of the metabotropic glutamate receptor-5
10/25/2006	EP1713785A1 Halogenated biaryl heterocyclic compounds and methods of making and using the same
10/25/2006	EP1713784A1 Imidazo-pyridazines, triazolo-pyridazines and related benzodiazepine receptor ligands
10/25/2006	EP1713782A1 Pth agonists
10/25/2006	EP1713781A1 Quinazoline derivatives
10/25/2006	EP1713780A2 Novel inhibitors of glutaminyl cyclase
10/25/2006	EP1713779A1 Indazole derivatives as inhibitors of hormone-sensitive lipases
10/25/2006	EP1713778A1 Benzazepine derivatives as histamine h3 antagonists
10/25/2006	EP1713776A1 Quinoline derivatives for use as mycobacterial inhibitors
10/25/2006	EP1713775A2 Chemical compounds
10/25/2006	EP1713774A1 New pyridin-2-one compounds useful as inhibitors of thrombin
10/25/2006	EP1713773A2 N-benzyl-3,4-dihyroxypyridine-2-carboxamide and n-benzyl-2,3-dihydroxypyridine-4-carboxamide compounds useful as hiv integrase inhibitors
10/25/2006	EP1713772A1 Novel piperidines as chemokine modulators (ccr)
10/25/2006	EP1713771A1 New crystalline form of perindopril
10/25/2006	EP1713770A1 Selective estrogen receptor modulators
10/25/2006	EP1713769A1 Amorphous tamsulosin hydrochloride
10/25/2006	EP1713768A2 Novel crystalline forms of entacapone and production thereof
10/25/2006	EP1713746A2 Method for producing dry powders of one or several carotenoids
10/25/2006	EP1713723A2 Fullerene based amino acids
10/25/2006	EP1713588A2 Method for the production of monodispersed pearl polymers containing acrylic
10/25/2006	EP1713543A2 Use of substituted 1,2,3 indolizine derivatives for treating diseases associated with a pathological angiogenesis
10/25/2006	EP1713542A2 COMBINATION OF (a) A DNA TOPOISOMERASE INHIBITOR AND (b) AN IAP INHIBITOR
10/25/2006	EP1713510A2 Growth factor-binding compounds attached to a calixarene
10/25/2006	EP1713507A2 Adept or gdept production of acetaldehyde
10/25/2006	EP1713506A1 Pharmaceutical compositions of neurokinin receptor antagonists and cyclodextrin and methods for improved injection site toleration
10/25/2006	EP1713490A1 Compositions for the treatment of atopic dermatitis, skin allergic conditions and acne
10/25/2006	EP1713489A2 Solid and crystalline ibandronate sodium and processes for preparation thereof
10/25/2006	EP1713488A1 Treatment of psychoses with quetiapine antipsychotic
10/25/2006	EP1713487A1 Diazabicyclic aryl derivatives as cholinergic receptor modulators
10/25/2006	EP1713486A1 Combination therapy for dementia,depression and apathy
10/25/2006	EP1713485A2 Treatment of degenerative cartilage conditions in a mammal with glycosidase inhibitors
10/25/2006	EP1713484A2 Compounds and methods of use
10/25/2006	EP1713483A1 Chemokine inhibiting piperazine derivatives and their use to treat multiple myeloma
10/25/2006	EP1713482A1 2-methoxy-5-(5-trifluoromethyl-tetrazol-1-yl-benzyl)-2s-phenyl-piperidin-3s-yl)-amine for the treatment of social phobia
10/25/2006	EP1713481A2 Novel uses for proton pump inhibitors
10/25/2006	EP1713480A2 The use of quaternary pyridinium salts as vasoprotective agents
10/25/2006	EP1713479A1 Nk-1 receptor antagonists anesthesia recovery
10/25/2006	EP1713478A1 Compositions comprising hiv protease inhibitor and cytochrome p450 enzyme activity inhibitor
10/25/2006	EP1713477A2 Combination of voriconazole and an antifungal cyp2c19 inhibitor
10/25/2006	EP1713476A2 Rabeprazole containing formulation
10/25/2006	EP1713475A1 1,3,5-trisubstituted 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity
10/25/2006	EP1713474A1 Indirubin derivatives having anticancer property against human cancer cell me
10/25/2006	EP1713473A1 The combination of anticholinergics and glucocorticoids for the long-term treatment of asthma and copd
10/25/2006	EP1713472A2 Treatment of rhinitis with anticholinergics alone in combination with antihistamines phosphodiesterase 4 inhibitors, or corticosteroids
10/25/2006	EP1713471A2 Combination of anticholinergics and inhibitors of phosphodiesterase type 4 for the treatment of respiratory diseases
10/25/2006	EP1713470A1 Therapeutic combinations
10/25/2006	EP1713469A1 Hypocholesterolemic compositions comprising a statin and an antiflatulent agent
10/25/2006	EP1713468A1 Anthelmintic composition
10/25/2006	EP1713467A1 Compositions and methods of use of a-type procyanidins

1 ... 4036 4037 4038 4039 4040 4041 4042 4043 4044 4045 4046 4047 4048 4049 4050 4051 4052 4053 4054 4055 4056 ... 7860